Anti-tumor activity of toll-like receptor 7 agonists

H Chi, C Li, FS Zhao, L Zhang, TB Ng, G Jin… - Frontiers in …, 2017 - frontiersin.org
Toll-like receptors (TLRs) are a class of pattern recognition receptors that play a bridging
role in innate immunity and adaptive immunity. The activated TLRs not only induce …

Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives

H Sun, Y Li, P Zhang, H Xing, S Zhao, Y Song… - Biomarker …, 2022 - Springer
Toll-like receptors (TLRs) are a large family of proteins that are expressed in immune cells
and various tumor cells. TLR7/8 are located in the intracellular endosomes, participate in …

Trial watch: TLR3 agonists in cancer therapy

J Le Naour, L Galluzzi, L Zitvogel, G Kroemer… - …, 2020 - Taylor & Francis
ABSTRACT Toll-like receptor 3 (TLR3) is a pattern recognition receptor that senses
exogenous (viral) as well as endogenous (mammalian) double-stranded RNA in …

Toll-like receptor 9 agonists in cancer

L Karapetyan, JJ Luke, D Davar - OncoTargets and therapy, 2020 - Taylor & Francis
Abstract Toll-like receptor 9 (TLR9) is a pattern recognition receptor that is predominantly
located intracellularly in immune cells, including dendritic cells, macrophages, natural killer …

Roles of toll-like receptor 3 in human tumors

X Zheng, S Li, H Yang - Frontiers in Immunology, 2021 - frontiersin.org
Toll-like receptor 3 (TLR3) is an important member of the TLR family, which is an important
group of pathogen-associated molecular patterns. TLR3 can recognize double-stranded …

Toll-like receptor-4 modulation for cancer immunotherapy

S Awasthi - Frontiers in immunology, 2014 - frontiersin.org
Toll-like receptors (TLRs) are evolutionarily conserved pattern recognition molecules. Since
the discovery of the Toll pathway cascade (1, 2), our knowledge about the structure, function …

Modes of action of TLR7 agonists in cancer therapy

S Kobold, G Wiedemann, S Rothenfußer… - Immunotherapy, 2014 - Taylor & Francis
From the numerous Toll-like receptor agonists, only TLR7 agonists have been approved for
cancer treatment, although they are current restricted to topical application. The main target …

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer

LAJ O'Neill, CE Bryant, SL Doyle - Pharmacological reviews, 2009 - ASPET
Since first being described in the fruit fly Drosophila melanogaster, Toll-like receptors (TLRs)
have proven to be of great interest to immunologists and investigators interested in the …

Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes

C Patinote, NB Karroum, G Moarbess, N Cirnat… - European journal of …, 2020 - Elsevier
The discovery of the TLRs family and more precisely its functions opened a variety of gates
to modulate immunological host responses. TLRs 7/8 are located in the endosomal …

Toll-like receptor 3 expressed by melanoma cells as a target for therapy?

B Salaun, S Lebecque, S Matikainen, D Rimoldi… - Clinical Cancer …, 2007 - AACR
Purpose: The immunomodulatory properties of Toll-like receptors (TLR) agonists have
inspired their use as experimental adjuvants for vaccination of cancer patients. However, it is …